← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 31, 2010Last known activity
Sep 30, 2025
Timeline
2000s
- Jan 1, 2004
JP Moulton Charitable Foundation— Founded
Drugs by trial phase (10 distinct, 10 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06519422CollaboratorPhase 3Sep 30, 2025
- NCT05539625CollaboratorPhase 2Sep 30, 2022
- NCT04913025CollaboratorPhase 2Oct 31, 2021
- NCT04521881CollaboratorPhase 3Nov 1, 2020
- NCT04276740CollaboratorPhase 2Apr 1, 2020
- NCT03875937CollaboratorPhase 1/Phase 2Aug 31, 2019
- NCT03840005CollaboratorPhase 2Dec 18, 2018
- NCT02216175CollaboratorN/AJul 19, 2018
- NCT01195480CollaboratorPhase 1/Phase 2May 1, 2012
- NCT00977366CollaboratorN/AMar 31, 2010
Details
- Founded
- London, GB Jan 1, 2004
- Last known activity
- Sep 30, 2025